Alendronate sodium and Dexamethasone sodium phosphate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Alendronate sodium (alendronate sodium) and Dexamethasone sodium phosphate (dexamethasone sodium phosphate). Common drug interactions include infection among females and gait disturbance among males.
The phase IV clinical study analyzes what interactions people have when they take Alendronate sodium and Dexamethasone sodium phosphate. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.
What is Alendronate sodium?
Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.
What is Dexamethasone sodium phosphate?
Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. eHealthMe is studying from 12,101 Dexamethasone sodium phosphate users. Check the latest studies of Dexamethasone sodium phosphate.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
36 people who take Alendronate sodium and Dexamethasone sodium phosphate together, and have interactions are studied.

What are the common drug interactions of Alendronate Sodium and Dexamethasone Sodium Phosphate, by gender? *:
female:
- Infection
- Iron deficiency anaemia
- Loss of consciousness
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
- Nausea (feeling of having an urge to vomit)
- Oral candidiasis (fungal infection of mouth)
- Pain in extremity
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Pneumonia pneumococcal (pneumococcal pneumonia is a common but serious infection and inflammation of the lungs)
- Psychomotor hyperactivity (feelings of extreme restlessness)
male:
- Gait disturbance
- Neuropathy peripheral (surface nerve damage)
- Abnormal behaviour
- Asthma
- Brain natriuretic peptide increased
- Cardiac failure acute
- Cardiac failure congestive
- Cardiomegaly (increased size of heart than normal)
- Delirium (wild excitement)
- Electrolyte imbalance
What are the common drug interactions of Alendronate Sodium and Dexamethasone Sodium Phosphate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Iron deficiency anaemia
- Malaise (a feeling of general discomfort or uneasiness)
- Malignant neoplasm progression (cancer tumour came back)
- Metastases to central nervous system (cancer spreads to central nervous system)
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Oral candidiasis (fungal infection of mouth)
- Pain in extremity
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
- Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
50-59:
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Multi-organ failure (multisystem organ failure)
- Pneumonia influenzal (the flu with pneumonia)
- Renal tubular necrosis (death of kidney tubules)
- Haemoglobin decreased
- Influenza
- White blood cell count decreased
60+:
- Herpes zoster
- Diarrhoea
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac failure
- Constipation
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Keratitis bacterial (inflammation of the cornea due to bacterial infection)
- Lung disorder (lung disease)
What are the existing conditions these people have? *
- Constipation: 9 people, 25.00%
- Nausea (feeling of having an urge to vomit): 7 people, 19.44%
- Diabetes: 6 people, 16.67%
- High Blood Pressure: 6 people, 16.67%
- Itching: 6 people, 16.67%
- Allergies: 5 people, 13.89%
- Anaesthesia: 5 people, 13.89%
- Insomnia (sleeplessness): 5 people, 13.89%
- Alanine Aminotransferase Increased: 4 people, 11.11%
- Sedation: 4 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Alendronate sodium and Dexamethasone sodium phosphate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Alendronate sodium (43,608 reports)
- Dexamethasone sodium phosphate (12,101 reports)
Browse all drug interactions of Alendronate sodium and Dexamethasone sodium phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alendronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dexamethasone sodium phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alendronate sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dexamethasone sodium phosphate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium and dexamethasone sodium phosphate (the active ingredients of Alendronate sodium and Dexamethasone sodium phosphate, respectively), and Alendronate sodium and Dexamethasone sodium phosphate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lipitor cause Arterial Occlusion? - 2 seconds ago
- Drug interactions of Adriamycin Pfs and Revlimid - 8 seconds ago
- Could Fuzeon cause Atrial Fibrillation/Flutter? - 22 seconds ago
- Alfenta and Nonspecific Back Pain for Men aged 50-59 - 23 seconds ago
- Alfenta and Pain - Back for Men aged 50-59 - 24 seconds ago
- Alfenta and Back Pain - Nonspecific for Men aged 50-59 - 24 seconds ago
- Alfenta and Back Pain for Men aged 50-59 - 24 seconds ago
- Could Voltaren cause Weakness? - 32 seconds ago
- Could Vicodin Es cause Diverticulum? - 35 seconds ago
- Risperdal and Fluoxetine drug interactions for boys aged 10-19 - 38 seconds ago